Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening programmes for foetomaternal alloimmune thrombocytopenia.

Vox sanguinis - 1 Jan 1998

Williamson L M

Abstract excerpt

Screening to detect pregnancies at risk of severe thrombocytopenia due to Foetomaternal alloimmunisation to Human Platelet Alloantigens (FAIT) is not yet a standard of care. Screening may be performed antenatally with the possibility of early intervention/therapy. Post natal measurement of cord platelet count may not always prevent fetal damage but may detect severe thrombocytopenia from other causes. Assessment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Platelets
Share to Fetal Blood
Share to Fetal Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genotype

Share to Infant, Newborn

Share to Isoantibodies

Share to Phenotype

Source

Identifiers

PMID: 9704471
DOI: 10.1111/j.1423-0410.1998.tb05446.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening programmes for foetomaternal alloimmune thrombocytopenia.PMID 9704471Read ↗

Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and managementSemantic proximity Read ↗

Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.Semantic proximity Read ↗

Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies.Semantic proximity Read ↗

Assessment of human platelet antigen (HPA)-1a alloimmunisation in women identified at increased risk for foetal and neonatal alloimmune thrombocytopaenia (FNAIT): a prospective, natural history studySemantic proximity Read ↗

Prenatal testing for hemolytic disease of the newborn and fetal neonatal alloimmune thrombocytopenia - current status.Semantic proximity Read ↗

Noninvasive Prenatal Testing in Immunohematology—Clinical, Technical and Ethical ConsiderationsSemantic proximity Read ↗

Fetal thrombocytopenia.Semantic proximity Read ↗

Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected casesSemantic proximity Read ↗

Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programmeSemantic proximity Read ↗

Antenatal management of fetal and neonatal alloimmune thrombocytopenia: Integration of clinical history and maternal HLA-DRB3*01:01 genotyping in clinical decision-making.Semantic proximity Read ↗

Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopeniaSemantic proximity Read ↗

New developments in fetal and neonatal alloimmune thrombocytopenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.